<DOC>
	<DOCNO>NCT02736591</DOCNO>
	<brief_summary>300 woman expect poor ovarian response ( POR ) undergo vitro fertilization intra-cytoplasmic sperm injection ( ICSI ) randomly divide 2 equal group use computer generate random number . Group 1 receive Dehydroepiandrosterone ( DHEA ) 25 mg ( DHEA 25mg , Natrol , USA ) t.d.s daily 12 week start IVF/ICSI cycle placebo similar growth hormone ( GH ) daily day 6 stimulation day human chorionic gonadotrophin ( hCG ) trigger . Group 2 receive oral placebo t.d.s . daily 12 week ICSI addition GH ( Somatotropin , Sedico , Egypt ) 4 IU day 6 hMG stimulation daily dose 2.5 mg subcutaneous ( SC ) day hCG trigger . Patients include study subject full history take clinical examination . On second day menstruation serum FSH , LH , Prolactin Oestradiol assess antral follicular count ( AFC ) assess use vaginal ultrasound scan . AFC define number follicle measure 3-10mm . All patient gonadotropin antagonist protocol Human menopausal gonadotrophin ( hMG ) stimulation day hCG administration . On day hCG administration , ovarian ultrasound scan perform use transvaginal probe . Oocytes aspirate 34-36 hour HCG administration . Oocytes fertilized embryo transfer . Both group compare regard proportion ongoing pregnancy .</brief_summary>
	<brief_title>Dehydroepiandrosterone Versus Growth Hormone Women Undergoing ICSI With Expected Poor Ovarian Response</brief_title>
	<detailed_description>The study conduct Cairo university hospital Dar Al-Teb Infertility Assisted conception center , Giza Egypt . All patient attend centre evaluate expect ovarian response . Patients fulfil Bologna criterion definition poor ovarian response invite participate study sign inform consent form . 300 woman expect poor ovarian response undergo IVF/ICSI randomly divide 2 equal group use computer generate random number . Group 1 receive DHEA 25 mg ( DHEA 25mg , Natrol , USA ) t.d.s daily 12 week start IVF/ICSI cycle placebo similar GH daily day 6 stimulation day hCG trigger . Group 2 receive oral placebo t.d.s . daily 12 week ICSI addition GH Growth hormone ( Somatotropin , Sedico , Egypt ) 4 IU day 6 hMG stimulation daily dose 2.5 mg SC day hCG trigger . Patients include study subject full history take clinical examination . On second day menstruation serum FSH , LH , Prolactin Oestradiol assess antral follicular count ( AFC ) assess use vaginal ultrasound scan . AFC define number follicle measure 3-10mm . All patient gonadotropin antagonist protocol Human menopausal gonadotrophin ( HMG ) stimulation day ( Human chorionic gonadotrophin ( HCG ) administration . On second day menstruation serum FSH , LH , Prolactin Oestradiol assess antral follicular count ( AFC ) assess use vaginal ultrasound scan . AFC define number follicle measure 3-10mm . The stimulation protocol start day 2 use 450-300 IU HMG ( Merional速 IBSA , Lugano , Switzerland ) gonadotrophin release hormone antagonist , cetrorelix ( Cetrotide速 Merck Serono , Darmstadt , Germany ) 0.025 mg daily . Gonadotropins administer 4 5 day , dose adjust accord ovarian response . The ovarian response monitor transvaginal ultrasound serum E2 level . When three follicle reach maximum diameter 16 mm , highly purify HCG 5000 10,000 IU ( Choriomon 速IBSA ) administer . The procedure cancel less 3 follicle 16 mm size present 12 day start gonadotropin despite dos reach 450 IU . The cycle also cancel risk ovarian hyperstimulation like massive ovarian enlargement serum estradiol exceed 3000pg/L Transvaginal oocyte retrieval perform 34-36 h administration HCG . Oocytes fertilized either via IVF ICSI base couple 's history . Fertilization assess 16-18 h IVF ICSI . Embryos transfer Day 3 5 . Vaginal tablet contain progesterone ( Prontogest速 IBSA ) 400 mg/day give fertilization confirm . A pregnancy test do 2 week embryo transfer . For patient positive pregnancy test , progesterone continue additional 4 week . Clinical pregnancy define Visualization intrauterine gestational sac 5 week embryo transfer . And ongoing pregnancy define sonographic confirmation fetal heart pulsation 12 week . Sample size calculation : Investigators plan study independent case control 1 control ( ) per case . Kotb et al find ongoing pregnancy rate woman undergo IVF/ICSI expect POR accord Bologna control 0.285 . On hand Bassiouny et al find ongoing pregnancy rate woman undergo ICSI expect POR receive growth hormone 0.147 , investigator need study 138 case patient receive DHEA 138 patient receive GH able reject null hypothesis ongoing pregnancy rate DHEA GH equal probability ( power ) 0.8 . Investigators add 12 patient arm account miss data dropout patient . The Type I error probability associate test null hypothesis 0.05 . Investigators use uncorrected chi-squared statistic evaluate null hypothesis . The primary outcome ongoing pregnancy rate define sonographic confirmation fetal heart beat 12 week gestation .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>woman undergo IVF/ICSI POR accord Bologna criterion Body mass index &gt; 35 Kg/m2 . woman single ovary . Allergy DHEA . Diabetic woman insulin insulin lower DHEA level might reduce effectiveness</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>